Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

David M. Kurtz, Loren K. Tschetter, Jacob B. Allred, Susan M. Geyer, Paul J. Kurtin, Wesley D. Putnam, Kendrith M. Rowland, Martin Wiesenfeld, Gamini S. Soori, Richard C. Tenglin, Albert M. Bernath, Thomas E. Witzig

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51'. Together they form a unique fingerprint.

Medicine & Life Sciences